AzTrials
AzTrials

Self EfficacyNCT05290103

Promoting Early Adolescent Non-smoking With a Game Intervention Supporting Self-efficacy

A study testing Game intervention in people with Self Efficacy and Smoking, run by University of Turku at 1 site in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This intervention study evaluates the effectiveness of a digital game intervention supporting smoking refusal self-efficacy among early adolescents (10-13 y). The participants are randomly allocated to two groups: the experimental group that receives the digital game intervention, and the control group that receives… Read more about this study

Who is it for?
Ages 10 to 13 yearsHealthy volunteers can take part
Conditions the study is for
Self Efficacy, Smoking
What is being tested?
Game intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
781 participants
Where
1 siteFinland
Study dates
1 Feb 2022to 5 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 13 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Goes to school at 4th, 5th, or 6th grade
  • Sufficient skills in Finnish or Swedish

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • Primary schools (n=15)

    Nine Cities

Other trials in Finland

About this study

This intervention study evaluates the effectiveness of a digital game intervention supporting smoking refusal self-efficacy among early adolescents (10-13 y). The participants are randomly allocated to two groups: the experimental group that receives the digital game intervention, and the control group that receives no intervention.

Being tested
Game intervention
Medical subject headings
Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Game interventionBehavioural

    Game intervention consists of 15-30 minutes digital health game playing at school and 2 weeks free usage of the digital health game during free time. In addition, after the 2 weeks period of game playing, 30-minute debriefing sessions with a research are held.

    The digital health game includes visualized elements with sound effects that aim at increasing understanding about the consequences of tobacco product use and supporting refusal skills. The health game includes different mini-games and also textual information.

    The debriefing sessions with a researcher include small group and group discussions about the themes presented in the game. A researcher leads and teachers facilitate the discussions. The debriefing sessions aim to connect the game experience with daily life situations.

Study groups in NCT05290103
Study groupRoleWhat they receive
Game interventionExperimentalParticipants in this arm will receive the game intervention including 15-30 minutes of digital health game playing at school and 2 weeks of free usage of the game during free time and a 30-minute debriefing session with a researcher.
Receives: Behavioral: Game intervention
No interventionNo interventionThe participants in this arm will receive no intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in smoking refusal self-efficacy

    Assessed with a smoking refusal self-efficacy scale (scores 6-24; higher scores indicate stronger smoking refusal self-efficacy).

    Measured: At baseline, at 2 weeks, and at 3 months

Secondary outcomes (2)
  1. Change in sources of refusal self-efficacy related to tobacco use

    Subscales for cigarette use (7 items) and snus use (7 items). Both are assessed with a 4-point Likert-scale questionnaire.

    Measured: At baseline, at 2 weeks, and at 3 months

  2. Change in motivation to decline tobacco use in the future

    Subscales for cigarette use and snus use. Both are assessed with a 4-point Likert-scale questionnaire (scores 1-4, lower scores indicate stonger motivation to decline tobacco use in future).

    Measured: At baseline, at 2 weeks, and at 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2022
  2. Study start1 Feb 2022
  3. Primary completion5 Jun 2022
  4. Study completion5 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
781 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05290103
Sponsor's protocol ID
PEANS2022
Status last verified
May 2023
First submitted
10 Mar 2022
Last updated
10 May 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Game intervention in people with Self Efficacy and Smoking, run by University of Turku at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in smoking refusal self-efficacy (time frame: At baseline, at 2 weeks, and at 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 May 2023; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in